Gary J. Nabel
Gary J. Nabel's purchase track record
How the stock did after each of Gary J. Nabel's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/8/2024 | OPK | $200K | +40.0% | +29.0% | +17.0% |
| 5/5/2023 | OPK | $841K | +8.7% | -26.2% | +5.4% |
| 6/22/2022 | OPK | $597K | -23.7% | -53.0% | +3.1% |
| 5/12/2022 | OPK | $217K | -10.7% | -42.9% | +0.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Candel Therapeutics Issues Inducement Grants to New Employees. Candel Therapeutics disclosed standard inducement grants awarded to newly hired employees. Under Nasdaq rules, such grants require public disclosure when given as incentives to attract talent. This is routine corporate governance news with no material impact on the company's operations or financial position. The grants align with standard market practices for biotechnology firms building their teams.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
OPKO Health Shares Rise on $722M BioReference Asset Sale. OPKO Health announced it sold BioReference laboratory assets to Labcorp for $722 million, a key part of Labcorp’s up to $872 million acquisition. The transaction was reflected in a sharp increase in OPKO’s stock price. The deal highlights OPKO’s focus on divesting non‑core assets. The move follows Labcorp’s broader strategy to expand its laboratory services.
Transaction History
| SIGA | ▲ Buy | Option Exercise | 24,116 | — | 6/9/2026 | View on chart |
| SIGA | ▼ Sell | Other | 7,235 | $32K | 6/9/2026 | View on chart |
| CADL | ▲ Buy | Grant | 5,353 | $25K | 6/25/2025 | View on chart |
| SIGA | ▲ Buy | Option Exercise | 19,084 | — | 6/10/2025 | View on chart |
| SIGA | ▼ Sell | Other | 5,725 | $36K | 6/10/2025 | View on chart |
| OPK | ▲ Buy | Grant | 437,500 | $0 | 7/24/2024 | View on chart |
| SIGA | ▲ Buy | Option Exercise | 24,712 | — | 6/11/2024 | View on chart |
| SIGA | ▼ Sell | Other | 7,414 | $58K | 6/11/2024 | View on chart |
| OPK | ▲ Buy | Open Market | 108,695 | $101K | 1/8/2024 | View on chart |
| OPK | ▲ Buy | Open Market | 500 | $459 | 1/8/2024 | View on chart |
| OPK | ▲ Buy | Open Market | 106,989 | $99K | 1/8/2024 | View on chart |
| SIGA | ▲ Buy | Option Exercise | 14,620 | — | 6/13/2023 | View on chart |
| SIGA | ▼ Sell | Other | 4,386 | $27K | 6/13/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 19,285 | $34K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 3,185 | $6K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 27,777 | $50K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 27,624 | $50K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 79,334 | $144K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 19,475 | $36K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 10,928 | $20K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 28,538 | $52K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 26,407 | $49K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 54,945 | $100K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 34,338 | $63K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 54,346 | $100K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 20,009 | $37K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 54,054 | $100K | 5/5/2023 | View on chart |
| OPK | ▲ Buy | Open Market | 13,229 | $33K | 6/22/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 65,280 | $163K | 6/22/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 1,491 | $4K | 6/22/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 31,023 | $77K | 6/22/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 15,200 | $38K | 6/22/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 33,777 | $84K | 6/22/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 80,000 | $198K | 6/22/2022 | View on chart |
| SIGA | ▲ Buy | Option Exercise | 22,831 | — | 6/14/2022 | View on chart |
| SIGA | ▼ Sell | Other | 6,849 | $70K | 6/14/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 68,492 | $199K | 5/18/2022 | View on chart |
| OPK | ▲ Buy | Open Market | 6,979 | $18K | 5/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
SIGA Technologies Releases Q2 2026 Earnings Call Transcript
SIGA Technologies has released the full transcript of its Q2 2026 earnings call. The transcript provides details on the company's recent performance and outlook. Investors can review the call to understand the company's guidance and operational highlights. The release is a routine update but offers insight into the company's current status.
SIGA Technologies Releases Q2 2026 Earnings Call Transcript. SIGA Technologies has released the full transcript of its Q2 2026 earnings call. The transcript provides details on the company's recent performance and outlook. Investors can review the call to understand the company's guidance and operational highlights. The release is a routine update but offers insight into the company's current status.